Immunohistochemical Characterization of Three Monoclonal Antibodies Raised against the Epidermal Growth Factor and Its Receptor in Non-Small-Cell Lung Cancer: Their Potential Use in the Selection of Patients for Immunotherapy

Adequate methods to identify which lung cancer patients are most likely to benefit from the targeted drugs against both epidermal growth factor receptor/epidermal growth factor (EGFR/EGF) are needed. For this reason, we evaluated both the tissue reactivity of ior egf/r3 monoclonal antibody (Mab) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Rengifo, Charles E., Blanco, Rancés, Blanco, Damián, Cedeño, Mercedes, Frómeta, Milagros, Calzado, Enrique Rengifo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437353/
https://www.ncbi.nlm.nih.gov/pubmed/26317020
http://dx.doi.org/10.1155/2013/627845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437353/
https://www.ncbi.nlm.nih.gov/pubmed/26317020
http://dx.doi.org/10.1155/2013/627845

Ejemplares similares